Taking drug discovery to a new dimension
At PharmEnable Therapeutics we harness the power of chemical novelty, diversity and 3-dimensionality to design innovative therapies for hard-to-drug conditions.
With our proprietary drug discovery platform we can unlock challenging biological targets and ultimately improve patients’ lives.
EXPLORING NOVEL CHEMICAL SPACE
Unlocking astronomic possibilities of drug-like small molecules that are IP-free from the start.
3-DIMENSIONALITY AND COMPLEXITY
Replicating the specificity of biologics to tackle challenging targets and minimise unwanted side effects.
POWERED BY CHEMICAL DIVERSITY
Enabling the rapid and efficient discovery of multiple chemical series from a small number of starting molecules.
Averaging 5 synthetic steps, with a >90% synthetic success rate across all molecules.
Unlocking chemical space to design innovative drugs
A hybrid human/AI-based intelligent cheminformatics system that identifies the most suitable regions of chemical space and proposes the best chemical synthetic options to deliver active molecules against a given biological target.
Our proprietary and unique accessible chemical space. It is composed of novel virtual compounds with a high degree of complexity and diversity to ensure an efficient coverage of chemical space.
A multicomponent and modular system of state-of-the-art AI methods and gold standard computational tools for efficiently mining chemUNIVERSE for a given biological target.